Clinical Trials Browser

sargramostim × Genitourinary × 30 days × Clear all

NCT03600350 2026-06-01

pTVG-HP and Nivolumab in Patients With Non-Metastatic PSA-Recurrent Prostate Cancer

Phase 2 Active not recruiting

19 enrolled 10 charts

Prostatic Neoplasms